Shares of health care data and analytics vendor, Inovalon Holdings, Inc. (NASDAQ:INOV), detracted from performance, as its financial results fell short of investor expectations and the company reduced its guidance for the remainder of 2016. Management attributed the shortfall to two issues: price reductions in its retrospective risk adjustment unit, and a margin shortfall stemming from investments designed to drive long-term growth. We are hopeful that the company’s latent earnings power will soon become apparent.
From Baron Funds' Barron Asset Fund third-quarter 2016 commentary.
